https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-01 / Int J Hyperthermia 2007 May;23(3):267-75
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-01 / Int J Hyperthermia 2007 May;23(3):267-752007-05-01 00:00:002019-02-15 08:35:05Prediction of anti-tumour effect of thermochemotherapy with in vitro thermochemosensitivity testing for non-small cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-01 / Int J Hyperthermia 2007 May;23(3):303-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-01 / Int J Hyperthermia 2007 May;23(3):303-142007-05-01 00:00:002019-02-15 08:35:25On verification of hyperthermia treatment planning for cervical carcinoma patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-01 / Cancer Immunol. Immunother. 2007 Nov;56(11):1785-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-01 / Cancer Immunol. Immunother. 2007 Nov;56(11):1785-932007-05-01 00:00:002019-02-15 09:24:06TGF-beta insensitive dendritic cells: an efficient vaccine for murine prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-01 / Zhonghua Nan Ke Xue 2007 May;13(5):453-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-01 / Zhonghua Nan Ke Xue 2007 May;13(5):453-62007-05-01 00:00:002019-02-15 09:24:07[Changes of dendritic cells in prostate cancer and dendritic cell-based immunotherapy]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-01 / J. Immunother. 2007 May-Jun;30(4):425-37
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-01 / J. Immunother. 2007 May-Jun;30(4):425-372007-05-01 00:00:002019-02-15 09:11:47AFP-specific CD4+ helper T-cell responses in healthy donors and HCC patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-01 / Lancet Oncol. 2007 May;8(5):451-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-01 / Lancet Oncol. 2007 May;8(5):451-42007-05-01 00:00:002007-05-01 00:00:00Vaccination with dendritic cells transfected with mRNA-encoded folate-receptor-alpha for relapsed metastatic ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-20 / Clin. Immunol. 2007 Jun;123(3):298-310
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-20 / Clin. Immunol. 2007 Jun;123(3):298-3102007-04-20 00:00:002019-02-15 09:16:58Radiation-induced apoptosis along with local and systemic cytokine elaboration is associated with DC plus radiotherapy-mediated renal cell tumor regression
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-20 / J Transl Med 2007 Apr;5:19
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-20 / J Transl Med 2007 Apr;5:192007-04-20 00:00:002019-02-15 09:19:42Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-19 / Cancer Immunol. Immunother. 2007 Nov;56(11):1817-29
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-19 / Cancer Immunol. Immunother. 2007 Nov;56(11):1817-292007-04-19 00:00:002019-02-15 08:48:10DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-18 / Cancer Immunol. Immunother. 2007 Oct;56(10):1597-604
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-18 / Cancer Immunol. Immunother. 2007 Oct;56(10):1597-6042007-04-18 00:00:002019-02-15 08:38:11Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine
